Transgenic mice expressing a dominant negative alpha1 connexin fusion protein in neural crest cells were homozygote inviable, dying neonatally with right ventricular outflow tract malformations.
Targeted dominant negative inhibition of gap junctional communication in neural crest cells leads to neonatal lethality and right ventricular outflow tract malformations in mice, highlighting its critical role in cardiac development.
Transgenic mice were generated expressing an alpha1 connexin/beta-galactosidase fusion protein previously shown to exert dominant negative effects on gap junctional communication. RNase protection analysis and assays for beta-galactosidase enzymatic activity showed that the transgene RNA and protein are expressed in the embryo and adult tissues. In situ hybridization analysis revealed that in the embryo, expression was predominantly restricted to neural crest cells and their progenitors in the dorsal neural tube, regions where the endogenous alpha1 connexin gene is also expressed. Dye-coupling analysis indicated that gap junctional communication was inhibited in the cardiac neural crest cells. All of the transgenic lines were homozygote inviable, dying neonatally and exhibiting heart malformations involving the right ventricular outflow tract-the same region affected in the alpha1 connexin knockout mice. As in the knockout mice, the conotruncal heart malformations were accompanied by outflow tract obstruction. Histological analysis showed that this was associated with abnormalities in the differentiation of the conotruncal myocardium. These results suggest that the precise level of gap junctional communication in cardiac neural crest cells is of critical importance in right ventricular outflow tract morphogenesis. Consistent with this possibility is the fact that cardiac crest cells from the alpha1 connexin knockout mice also exhibited a greatly reduced level of gap junctional communication. These studies show the efficacy of a dominant negative approach for manipulating gap junctional communication in the mouse embryo and demonstrate that targeted expression of this fusion protein can be a powerful tool for examining the role of gap junctions in mammalian development.
Sullivan et al. (Tue,) conducted a other in Heart malformations. Expression of alpha1 connexin/beta-galactosidase fusion protein vs. alpha1 connexin knockout mice was evaluated on Viability and heart malformations. Transgenic mice expressing a dominant negative alpha1 connexin fusion protein in neural crest cells were homozygote inviable, dying neonatally with right ventricular outflow tract malformations.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: